- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Pharmacyclics Inc
+ Add to WatchlistPCYC:US
85.6100 USD 0.0100 0.01%As of 20:10:00 ET on 05/24/2013.
Company Profile for Pharmacyclics Inc (PCYC)
Pharmacyclics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. The Company's pharmaceutical drug development candidates are synthetic small-molecules designed to target key biochemical pathways involved in human diseases with critical unmet needs.
Contact Information
Pharmacyclics Inc
995 East Arques Avenue
Sunnyvale, CA 94085-4521
United States
Key Executives for Pharmacyclics Inc (PCYC)
| Robert W Duggan "Bob"Chairman/CEO | Mahkam Zanganeh "Maky"Chief Operating Officer |
| Lori A KunkelChief Medical Officer | Maria FardisChief:Oncology Ops & Alliances |
| Heow TanChief:Technical Operations | Joshua T BrummExecutive VP:Finance |
| Paula S BoultbeeExecutive VP:Sales & Marketing | Rainer M Erdtmann "Ramses"Senior VP:Investor Relations |
| Urte GaykoSenior VP:Regulatory | Richard Love "Rick"VP/Secretary/General Counsel |
| Manmeet SoniVP/Controller | Fong Wang ClowVP:Biostatistics |
| Gregory W HemmiVP:Chemical Operations | Jesse McGreivyVP:Clinical Science |
| Dana LeeVP:Clinical Drug Safety | Scott ShearerVP:Global Quality |
| Christophe SuchetVP:Information Technology | Elizabeth FaustVP:Medical Affairs |
| David J LouryVP:Preclinical Sciences/CSO | Joseph J BuggyVP:Research |
| Michael CrumVP:US Sales |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page